The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTDesign of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acidsD. W. Cushman, H. S. Cheung, E. F. Sabo, and M. A. OndettiCite this: Biochemistry 1977, 16, 25, 5484–5491Publication Date (Print):December 13, 1977Publication History Published online1 May 2002Published inissue 13 December 1977https://doi.org/10.1021/bi00644a014RIGHTS & PERMISSIONSArticle Views2361Altmetric-Citations721LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InReddit PDF (990 KB) Get e-AlertsSupporting Info (1)»Supporting Information Supporting Information Get e-Alerts
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung
Cushman, D. W., & Cheung, H. S. (1971) · Biochemical Pharmacology · doi:10.1016/0006-2952(71)90292-9 · Cited by 2,625
Self-citationOndetti, M. A., Rubin, B., & Cushman, D. W. (1977) · Science · doi:10.1126/science.191908 · Cited by 1,856
Self-citationTHE PREPARATION AND FUNCTION OF THE HYPERTENSIN-CONVERTING ENZYME
Skeggs, L. T., Kahn, J. R., & Shumway, N. P. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.103.3.295 · Cited by 1,032
Ondetti, M. A., Williams, N. J., Sabo, E., Pluscec, J., Weaver, E. R., & Kocy, O. (1971) · Biochemistry · doi:10.1021/bi00798a004 · Cited by 521
Self-citationIsolation of bradykinin-potentiating peptides from Bothrops jararaca venom
J.P. (1971) · Toxicon · doi:10.1016/0041-0101(71)90098-5 · Cited by 480
Carboxypeptidase A: A Protein and an Enzyme
Quiocho, F. A., & Lipscomb, W. N. (1971) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60278-8 · Cited by 400
Gavras, H., Brunner, H. R., Laragh, J. H., Sealey, J. E., Gavras, I., & Vukovich, R. A. (1974) · New England Journal of Medicine · doi:10.1056/nejm197410172911603 · Cited by 353
CHARACTERIZATION OF A DIPEPTIDE HYDROLASE (KININASE II: ANGIOTENSIN I CONVERTING ENZYME)
YANG, H. Y. T., ERDÖS, E. O., & LEVIN, Y. (1971) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)28878-4 · Cited by 295
Anomalous cleavage of aspartyl-proline peptide bonds during amino acid sequence determinations
Piszkiewicz, D., Landon, M., & Smith, E. L. (1970) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(70)90918-6 · Cited by 291
Cheung, H. S., & Cushman, D. W. (1973) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(73)90352-5 · Cited by 271
Self-citation
Cited by
The influence of natural products upon drug discovery (Antiquity to late 1999)
Newman, D. J., Cragg, G. M., & Snader, K. M. (2000) · Natural Product Reports · doi:10.1039/a902202c · Cited by 1,293
Crystal structure of the human angiotensin-converting enzyme–lisinopril complex
Natesh, R., Schwager, S. L. U., Sturrock, E. D., & Acharya, K. R. (2003) · Nature · doi:10.1038/nature01370 · Cited by 888
Cheung, H. S., Wang, F. L., Ondetti, M. A., Sabo, E. F., & Cushman, D. W. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86187-2 · Cited by 745
Self-citationA new class of angiotensin-converting enzyme inhibitors
Patchett, A. A., Harris, E., Tristram, E. W., Wyvratt, M. J., Wu, M. T., Taub, D., Peterson, E. R., Ikeler, T. J., ten Broeke, J., Payne, L. G., et al. (1980) · Nature · doi:10.1038/288280a0 · Cited by 699
Structural basis of the action of thermolysin and related zinc peptidases
Matthews, B. W. (1988) · Accounts of Chemical Research · doi:10.1021/ar00153a003 · Cited by 687
Yamamoto, N., Akino, A., & Takano, T. (1994) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(94)77026-0 · Cited by 418
Schwartz, J.-C., Malfroy, B., & De La Baume, S. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90182-x · Cited by 381
Ace revisited: A new target for structure-based drug design
Acharya, K. R., Sturrock, E. D., Riordan, J. F., & Ehlers, M. R. W. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1227 · Cited by 342
Arendse, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Burnett, J. C., Llorens-Cortes, C., Ehlers, M. R., & Sturrock, E. D. (2019) · Pharmacological Reviews · doi:10.1124/pr.118.017129 · Cited by 339
Keynote review: Structural biology and drug discovery
Congreve, M., Murray, C. W., & Blundell, T. L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03484-7 · Cited by 338
The Discovery of Ezetimibe: A View from Outside the Receptor
Clader, J. W. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030283g · Cited by 325
Bordon, K. D. C. F., Cologna, C. T., Fornari-Baldo, E. C., Pinheiro-Júnior, E. L., Cerni, F. A., Amorim, F. G., Anjolette, F. A. P., Cordeiro, F. A., Wiezel, G. A., Cardoso, I. A., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01132 · Cited by 303
Natesh, R., Schwager, S. L. U., Evans, H. R., Sturrock, E. D., & Acharya, K. R. (2004) · Biochemistry · doi:10.1021/bi049480n · Cited by 295
History of the design of captopril and related inhibitors of angiotensin converting enzyme.
Cushman, D. W., & Ondetti, M. A. (1991) · Hypertension · doi:10.1161/01.hyp.17.4.589 · Cited by 270
Self-citationRecent developments in the design of angiotensin‐converting enzyme inhibitors
Wyvratt, M. J., & Patchett, A. A. (1985) · Medicinal Research Reviews · doi:10.1002/med.2610050405 · Cited by 253
2-Oxoglutarate analogue inhibitors of hif prolyl hydroxylase
Mole, D. R., Schlemminger, I., McNeill, L. A., Hewitson, K. S., Pugh, C. W., Ratcliffe, P. J., & Schofield, C. J. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00539-0 · Cited by 145
Unlocking the Potential of Retro-Inverso (RI) Peptides as Future Drug Candidates
Al Musaimi, O. (2024) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-024-10639-1 · Cited by 18
Metadata
- Authors
- Cushman, D. W., Cheung, H. S., Sabo, E. F., & Ondetti, M. A.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1977-12-13
- Volume
- 16
- Issue
- 25
- Pages
- 5484-5491
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2067763402
- Cited by
- 892
- References
- 16
- FWCI
- 23.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.